Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Importers Notice of Registration - 2017 > Importer of Controlled Substances Registration

Importers Notice of Registration - 2017

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Pages 14913-14914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05730]


Drug Enforcement Administration

[Docket No. DEA-392]

Importer of Controlled Substances Registration

ACTION: Notice of registration.

SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

[[Page 14914]]

Company FR Docket Published
Fisher Clinical Services, Inc. 81 FR 61248 September 6, 2016
Sigma-Aldrich International:    
      GMBH-Sigma Aldrich Company LLC 81 FR 63223 September 14, 2016
      Fisher Clinical Services, Inc. 81 FR 68455 October 4, 2016
      Anderson Brecon, Inc. 81 FR 71766 October 18, 2016
      Johnson Matthey Inc. 81 FR 71766 October 18, 2016
      Wildlife Laboratories, Inc. 81 FR 95644 December 28, 2016
      Noramco, Inc. 81 FR 95640 December 28, 2016
      Mylan Technologies, Inc. 82 FR 7859 January 23, 2017

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Dated: March 17, 2017.

Louis J. Milione,
Assistant Administrator.

[FR Doc. 2017-05730 Filed 3-22-17; 8:45 am]


NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility